RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sellas Life Sciences Group - Stock

Sellas Life Sciences Group Market capitalization 2024

Sellas Life Sciences Group Market capitalization

41.67 M USD

Ticker

SLS

ISIN

US81642T2096

WKN

A2PU3T

In 2024, Sellas Life Sciences Group's market cap stood at 41.67 M USD, a -6.25% increase from the 44.44 M USD market cap in the previous year.

The Sellas Life Sciences Group Market capitalization history

YEARREVENUE (undefined USD)GROSS MARGIN (%)NET INCOME (undefined USD)
2029e244.250,37202.4
2028e157.240,57111.99
2027e200.660,4528.87
2026e99.530,90-18.96
2025e32.32,79-31.21
2024e---40.83
2023---37.34
2022190,00-41.3
20217.697,37-20.7
20201.947,37-16.84
2019---27.95
2018---41.25
2017---24.43
2016---17.68
2015---63.9
20149.3284,98-36.61
2013---76.68
2012---34.97
2011---11.49
2010---11.99
2009---18.39
2008---14.37
2007---10.99
2006---2.41
2005---2.21
2004---3.27

Sellas Life Sciences Group Aktienanalyse

What does Sellas Life Sciences Group do?

Sellas Life Sciences Group Inc is a biopharmaceutical company specializing in the development and marketing of products for the treatment of cancer. It was founded in 2012 and is headquartered in New York City. The company's history began with the discovery of a groundbreaking drug called "Galiximab," which can be used to treat lymph node cancer. In recent years, Sellas Life Sciences Group Inc has also advanced the development of immunotherapy products that harness the body's immune system to fight malignant cancer cells. The company's business model is focused on developing pharmaceutical products and providing clinical services. It has various divisions dedicated to the development of cancer therapies, including research and development partnerships with leading institutions such as the Memorial Sloan-Kettering Cancer Center, the National Cancer Institute, and the Dana-Farber Cancer Institute. Sellas aims to improve the lives of cancer patients through the development of advanced therapies. Sellas Life Sciences Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Sellas Life Sciences Group's Market Capitalization

Sellas Life Sciences Group's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Sellas Life Sciences Group's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Sellas Life Sciences Group's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Sellas Life Sciences Group’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Sellas Life Sciences Group Stock

What is the current Sellas Life Sciences Group market capitalization?

The current market capitalization of Sellas Life Sciences Group is 41.67 M USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Sellas Life Sciences Group.

How has the market capitalization of Sellas Life Sciences Group developed in recent years?

The market capitalization of Sellas Life Sciences Group has increased/decreased by -6.25% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Sellas Life Sciences Group?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Sellas Life Sciences Group?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Sellas Life Sciences Group have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Sellas Life Sciences Group pay?

Over the past 12 months, Sellas Life Sciences Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sellas Life Sciences Group is expected to pay a dividend of 0 USD.

What is the dividend yield of Sellas Life Sciences Group?

The current dividend yield of Sellas Life Sciences Group is .

When does Sellas Life Sciences Group pay dividends?

Sellas Life Sciences Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sellas Life Sciences Group?

Sellas Life Sciences Group paid dividends every year for the past 0 years.

What is the dividend of Sellas Life Sciences Group?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sellas Life Sciences Group located?

Sellas Life Sciences Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sellas Life Sciences Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sellas Life Sciences Group from 6/17/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/17/2024.

When did Sellas Life Sciences Group pay the last dividend?

The last dividend was paid out on 6/17/2024.

What was the dividend of Sellas Life Sciences Group in the year 2023?

In the year 2023, Sellas Life Sciences Group distributed 0 USD as dividends.

In which currency does Sellas Life Sciences Group pay out the dividend?

The dividends of Sellas Life Sciences Group are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Sellas Life Sciences Group stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Sellas Life Sciences Group

Our stock analysis for Sellas Life Sciences Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sellas Life Sciences Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.